Inferring tumour purity and stromal and immune cell admixture from expression data
Open accessThe DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Abstract
Infiltrating stromal and immune cells form the major fraction of normal cells in tumour tissue and not only perturb the tumour signal in molecular studies but also have an important role in cancer biology. Here we describe ‘Estimation of STromal and Immune cells in MAlignant Tumours using Expression data’ (ESTIMATE)—a method that uses gene expression signatures to infer the fraction of stromal and immune cells in tumour samples. ESTIMATE scores correlate with DNA copy number-based tumour purity across samples from 11 different tumour types, profiled on Agilent, Affymetrix platforms or based on RNA sequencing and available through The Cancer Genome Atlas. The prediction accuracy is further corroborated using 3,809 transcriptional profiles available elsewhere in the public domain. The ESTIMATE method allows consideration of tumour-associated normal cells in genomic and transcriptomic studies. An R-library is available on https://sourceforge.net/projects/estimateproject/ . Tumour biopsies contain contaminating normal cells and these can influence the analysis of tumour samples. In this study, Yoshihara et al.develop an algorithm based on gene expression profiles from The Cancer Genome Atlas to estimate the number of contaminating normal cells in tumour samples.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“this result is not merely a reflection of the extent of immune infiltration, as indicated by the lack of correlation between the γδ T cell signature score and ESTIMATE (Yoshihara et al., 2013) immune signature score for individual patients”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Yoshihara et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · cited 2×
“We devised two gene signatures: (1) a ‘stromal signature’ that was designed to capture the presence of stroma in tumour tissue, and (2) an ‘immune signature’ that aimed to represent the infiltration of immune cells in tumour tissue (Supplementary Data 1).”
MethodRSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome
Li, B., & Dewey, C. N. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-323 · Cited by 22,179
pROC: an open-source package for R and S+ to analyze and compare ROC curves
Robin, X., Turck, N., Hainard, A., Tiberti, N., Lisacek, F., Sanchez, J.-C., & Müller, M. (2011) · BMC Bioinformatics · doi:10.1186/1471-2105-12-77 · Cited by 13,697
Mapping and quantifying mammalian transcriptomes by RNA-Seq
Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L., & Wold, B. (2008) · Nature Methods · doi:10.1038/nmeth.1226 · Cited by 13,696
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Cited by
Items 301–400 of 1,021
Jiang, Y., Ma, D., Jin, X., Xiao, Y., Yu, Y., Shi, J., Zhou, Y.-F., Fu, T., Lin, C., Dai, L.-J., et al. (2024) · Nature Cancer · doi:10.1038/s43018-024-00725-0 · Cited by 131
“To confirm the robustness of the TME phenotypes, we adopted several other methods (CIBERSORT 25 , ESTIMATE 26 and single-cell RNA-seq (scRNA-seq) data-based TME deconvolution 27 ) and another cohort (TCGA dataset) (Extended Data Fig.”
MethodInfluentialEpigenomic Deconvolution of Breast Tumors Reveals Metabolic Coupling between Constituent Cell Types
Onuchic, V., Hartmaier, R. J., Boone, D. N., Samuels, M. L., Patel, R. Y., White, W. M., Garovic, V. D., Oesterreich, S., Roth, M. E., Lee, A. V., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.057 · Cited by 109
Yang, S., Liu, T., Nan, H., Wang, Y., Chen, H., Zhang, X., Zhang, Y., Shen, B., Qian, P.-D., Xu, S., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29018 · Cited by 116
“Many algorithms have recently been developed to predict tumor purity in various cancers based on the specific gene expression signature of immune or/and stromal cells (Li et al., 2016; Newman et al., 2015; Yoshihara et al., 2013).”
BackgroundMethodWang, S., Xiong, Y., Zhang, Q., Su, D., Yu, C., Cao, Y., Pan, Y., Lu, Q., Zuo, Y., & Yang, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa311 · Cited by 140
Weiner, A. B., Vidotto, T., Liu, Y., Mendes, A. A. D. A., Salles, D. C., Faisal, F. A., Murali, S., McFarlane, M., Imada, E. L., Zhao, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21245-w · Cited by 116
Martins, F. C., de Santiago, I., Trinh, A., Xian, J., Guo, A., Sayal, K., Jimenez‐Liñan, M., Deen, S., Driver, K. E., Mack, M. L., et al. (2014) · Genome biology · doi:10.1186/s13059-014-0526-8 · Cited by 117
“from the Yoshihara signature (141 genes, highlighted in red) are redistributed [22].”
BackgroundMethodInfluentialReinartz, S., Finkernagel, F., Adhikary, T., Rohnalter, V., Schumann, T., Schober, Y., Nockher, W. A., Nist, A., Stiewe, T., Jansen, J. M., et al. (2016) · Genome biology · doi:10.1186/s13059-016-0956-6 · Cited by 117
Widespread parainflammation in human cancer
Aran, D., Lasry, A., Zinger, A., Biton, M., Pikarsky, E., Hellman, A., Butte, A. J., & Ben-Neriah, Y. (2016) · Genome Biology · doi:10.1186/s13059-016-0995-z · Cited by 109
“, by the ESTIMATE score [35].”
Cao, R., Yuan, L., Ma, B., Wang, G., Qiu, W., & Tian, Y. (2019) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02649-x · Cited by 121
Zheng, J., Zhou, Z., Qiu, Y., Wang, M., Yu, H., Wu, Z., Wang, X., & Jiang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.675555 · Cited by 117
“Evaluation of the Immune Landscape The immune scores and stromal scores of glioma patients were calculated using the ESTIMATE algorithm via the R package “estimate” (Yoshihara et al., 2013).”
MethodRadiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer
Jiang, L., You, C., Xiao, Y., Wang, H., Su, G.-H., Xia, B., Zheng, R., Zhang, D.-D., Jiang, Y., Gu, Y., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100694 · Cited by 117
“The RNA-based immune cell signatures revealed a major difference in the microenvironment between tumorswith high and lowperitumor heterogeneity (Figures 5A and 5B).(22) LowPeri_V_DNwas characterized by a higher abundance of CD8 T cells, naive CD4 T cells, gd T cells, activated nature killer (NK) cells, M1 macrophages,…”
BackgroundLiang, W.-W., Lu, R. J.-H., Jayasinghe, R. G., Foltz, S. M., Porta-Pardo, E., Geffen, Y., Wendl, M. C., Lazcano, R., Kolodziejczak, I., Song, Y., et al. (2023) · Cancer Cell · doi:10.1016/j.ccell.2023.07.013 · Cited by 105
Self-citationLiu, Z., Zhang, Y., Shi, C., Zhou, X., Xu, K., Jiao, D., Sun, Z., & Han, X. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-020-02697-y · Cited by 138
Angelis, C. D., Fu, X., Cataldo, M. L., Nardone, A., Pereira, R., Veeraraghavan, J., Nanda, S., Qin, L., Sethunath, V., Wang, T., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-4191 · Cited by 109
“Since stromal and immune cells are thought to represent the primary sources of IFN in many tumor tissues, we first analyzed the correlation between IRPS scores and altered stromal and immune infiltration as defined by the ESTIMATE method in TCGA ER+/HER2- tumors (25) (Fig.”
A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers
Peng, L., Li, J., Wu, J., Xu, B., Wang, Z., Giamas, G., Stebbing, J., & Yu, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.762598 · Cited by 105
“TIICs were analyzed including T cells (general), CD8+ T cells, B cells, monocytes, TAMs, M1 macrophages, M2 macrophages, DCs, neutrophils, natural killer (NK) cells, follicular helper T (Tfh) cells, T-helper 1 (Th1) cells, T-helper 2 (Th2) cells, Thelper 17 (Th17) cells, exhausted T cells, Tregs, and mast cells (5).”
BackgroundZhang, C., Zeng, Y., Guo, X., Shen, H., Zhang, J., Wang, K., Ji, M., & Huang, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.923737 · Cited by 117
“In order to analyze the infiltration levels of immune cells and stromal cells in pan-cancer, we used ESTIMATE to determine the correlation between FDX1 expression and immune score, stromal score (Yoshihara et al., 2013).”
MethodSelf-citationPan-cancer proteogenomics characterization of tumor immunity
Petralia, F., Ma, W., Yaron, T. M., Caruso, F. P., Tignor, N. L., Wang, J. M., Charytonowicz, D., Johnson, J. L., Huntsman, E. M., Marino, G. B., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.027 · Cited by 113
Self-citationZhu, T., Liu, J., Beck, S., Pan, S., Capper, D., Lechner, M., Thirlwell, C., Breeze, C. E., & Teschendorff, A. E. (2022) · Nature Methods · doi:10.1038/s41592-022-01412-7 · Cited by 103
Genomic Signatures Predict the Immunogenicity of BRCA-Deficient Breast Cancer
Kraya, A., Maxwell, K. N., Wubbenhorst, B. S., Wenz, B. M., Pluta, J. B., Rech, A. J., Dorfman, L. M., Lunceford, N., Barrett, A., Mitra, N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0468 · Cited by 109
“org Clin Cancer Res; 25(14) July 15, 2019 4371”
BackgroundMethodInfluentialHao, Y., Yan, M., Heath, B. R., Lei, Y. L., & Xie, Y. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1006976 · Cited by 103
Astrocytes enhance glioblastoma growth
Mega, A., Nilsen, M. H., Leiss, L. W., Tobin, N. P., Miletić, H., Sleire, L., Strell, C., Nelander, S., Krona, C. C., Hägerstrand, D., et al. (2019) · Glia · doi:10.1002/glia.23718 · Cited by 103
“The ESTIMATE stromal score (Yoshihara et al., 2013) was used to infer the stroma abundance in the TCGA cases.”
MethodXu, J., Shao, T., Song, M., Xie, Y., Zhou, J., Yin, J., Ding, N., Zou, H., Li, Y., & Zhang, J. (2020) · Molecular Cancer · doi:10.1186/s12943-020-01174-w · Cited by 104
Umeda, M., Ma, J., Huang, B. J., Hagiwara, K., Westover, T., Abdelhamed, S., Barajas, J. M., Thomas, M. E., Walsh, M. P., Song, G., et al. (2022) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0160 · Cited by 107
“Tumor purity was estimated from RNA-seq data using ESTIMATE (47) algorithm.”
MethodGenomic and immune landscape Of metastatic pheochromocytoma and paraganglioma
Calsina, B., Piñeiro-Yáñez, E., Martínez‐Montes, Á. M., Caleiras, E. J., Fernández-Sanromán, Á., Monteagudo, M., Torres‐Pérez, R., Torre, C. F., Pulgarín-Alfaro, M., Gil, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36769-6 · Cited by 126
McGrail, D. J., Federico, L., Li, Y., Dai, H., Lu, Y., Mills, G. B., Yi, S., Lin, S.-Y., & Sahni, N. (2018) · Nature Communications · doi:10.1038/s41467-018-03730-x · Cited by 95
Self-citationPrognostic significance of immune landscape in tumour microenvironment of endometrial cancer
Li, B., & Wan, X. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15408 · Cited by 122
Jin, Y., Wang, Z., He, D., Zhu, Y., Chen, X., & Cao, K. (2021) · Cancer Medicine · doi:10.1002/cam4.4341 · Cited by 107
Glioblastoma epigenome profiling identifies SOX10 as a master regulator of molecular tumour subtype
Wu, Y., Fletcher, M., Gu, Z., Wang, Q., Costa, B., Bertoni, A., Man, K.-H., Schlotter, M., Felsberg, J., Mangei, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20225-w · Cited by 101
Statistical Methods in Integrative Genomics
Richardson, S., Tseng, G. C., & Sun, W. (2016) · Annual Review of Statistics and Its Application · doi:10.1146/annurev-statistics-041715-033506 · Cited by 100
“Recent studies have shown that gene expression (Yoshihara et al. 2013) or DNA methylation (Zheng et al. 2014) might also be informative and thus integrative approach may be useful for cancer subclone studies.”
Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma
Xiang, S., Li, J., Shen, J., Zhao, Y., Wu, X., Li, M., Yang, X., Kaboli, P. J., Du, F., Zheng, Y., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.653836 · Cited by 113
“In addition, the algorithm can also predict tumor purity, which helps understand the influence of the microenvironment on neoplastic cells (23).”
BackgroundPingili, A. K., Chaib, M., Sipe, L. M., Miller, E. J., Teng, B., Sharma, R., Yarbro, J. R., Asemota, S., Abdallah, Q. A., Mims, T. S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109285 · Cited by 104
“The immune score (Yoshihara et al., 2013) predicts immune cell infiltration in bulk RNA sequencing (RNA-seq) samples and was elevated by anti-PD-1 (Figure 3B).”
BackgroundLiu, X., Mei, W., Padmanaban, V., Alwaseem, H., Molina, H., Passarelli, M. C., Tavora, B., & Tavazoie, S. F. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.05.008 · Cited by 106
de Jong, F. C., Laajala, T. D., Hoedemaeker, R. F., Jordan, K. R., van der Made, A. C. J., Boevé, E. R., van der Schoot, D. K. E., Nieuwkamer, B. B., Janssen, E. A. M., Mahmoudi, T., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abn4118 · Cited by 111
“(A) Boxplots predicting tumor purity and immune infiltration in n = 283 pre-BCG tumors grouped by BRS (25); P values are based on the Kruskal-Wallis tests.”
MethodSystematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR
Fang, Y., Kong, Y., Rong, G., Luo, Q., Liao, W., & Zeng, D. (2025) · Med Research · doi:10.1002/mdr2.70001 · Cited by 147
Rhee, J., Jung, Y. C., Kim, K. R., Yoo, J., Kim, J., Lee, Y., Ko, Y. H., Lee, H. H., Cho, B. C., & Kim, T. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0201 · Cited by 113
“The extent of nontumor cell contamination or tumor purity (the proportion of tumor cells in the mixture) can be estimated by histologic examination or computational methods using various genomic resources (5, 6).”
BackgroundLe, T., Aronow, R. A., Kirshtein, A., & Shahriyari, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa219 · Cited by 109
Martínez-Ledesma, E., Verhaak, R. G. W., & Treviño, V. (2015) · Scientific Reports · doi:10.1038/srep11966 · Cited by 109
“This heterogeneity is reflected in the relatively high number of individuals (578) included in the TCGA ovarian dataset 16 , although a similar number of samples was included in glioblastoma and invasive breast carcinoma (Table 1).”
BackgroundSelf-citationChen, P., Yang, Y., Zhang, Y., Jiang, S., Li, X., & Wan, J. (2020) · Aging · doi:10.18632/aging.102817 · Cited by 114
“ESTIMATE (Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data) is one of the algorithms developed to evaluate the cell tumor composition by calculating the immune and stromal scores using Pearson’s correlation coefficient [6].”
MethodLiu, Y., Wu, J., Huang, W., Weng, S., Wang, B., Chen, Y., & Wang, H. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02366-0 · Cited by 99
He, L., Fan, Y., Zhang, Y., Tu, T.-T., Zhang, Q., Yuan, F., & Cheng, C. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12803 · Cited by 105
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicine
Conway, J. R. W., Herrmann, D., Evans, T. J., Morton, J. P., & Timpson, P. (2018) · Gut · doi:10.1136/gutjnl-2018-316822 · Cited by 104
“51 Beyond purity assessment, this approach facilitated assessment of GPs associated with microenvironmental factors, such as hypoxia, ECM deposition and activated immune pathways.”
Hussain, A., Voisin, V., Poon, S., Karamboulas, C., Bui, N. H. B., Meens, J., Dmytryshyn, J., Ho, V. W., Tang, K. H., Paterson, J., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20191094 · Cited by 109
“olds, and ESTIMATE and ABSOLUTE values, which are known to measure percentage of stromal cell and tumor purity content, respectively (Carter et al., 2012; Yoshihara et al., 2013), were determined using the respective R packages.”
MethodSun, D., Liu, J., Zhou, H., Shi, M., Sun, J., Zhao, S., Chen, G., Zhang, Y., Zhou, T., Ma, Y., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.03.012 · Cited by 102
β-Catenin–mediated immune evasion pathway frequently operates in primary cutaneous melanomas
Nsengimana, J., Laye, J., Filia, A., O’Shea, S., Muralidhar, S., Poźniak, J., Droop, A., Chan, M., Walker, C., Parkinson, L., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95351 · Cited by 96
“To evaluate this scoring scheme, we plotted key immune cell scores alongside the CICs, and the innate versus the adaptive immune score, and compared the total score with an equivalent score calculated using the published software ESTIMATE (18).”
InfluentialBIRC5 is a prognostic biomarker associated with tumor immune cell infiltration
Xu, L., Yu, W., Xiao, H., & Kang, L. (2021) · Scientific Reports · doi:10.1038/s41598-020-79736-7 · Cited by 113
Wang, J., Wang, Q., Guan, Y., Sun, Y., Wang, X., Lively, K., Wang, Y., Luo, M., Kim, J. A., Murphy, E. A., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci157248 · Cited by 101
“The tumor purity was 505 estimated by ESTIMATE (45) and the association analysis were performed on the platform 506 of SCISSORTM (46).”
Pancreatic cancer–restricted cryptic antigens are targets for T cell recognition
Ely, Z. A., Kulstad, Z. J., Günaydın, G., Addepalli, S., Verzani, E. K., Casarrubios, M., Clauser, K. R., Wang, X., Lippincott, I. E., Louvet, C., et al. (2025) · Science · doi:10.1126/science.adk3487 · Cited by 101
Lee, T.-Y., Huang, K.-Y., Chuang, C.-H., Lee, C.-Y., & Chang, T.-H. (2020) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2020.107277 · Cited by 95
Beane, J., Mazzilli, S. A., Campbell, J. D., Duclos, G. E., Krysan, K., Moy, C. H., Perdomo, C., Schäffer, M., Liu, G., Zhang, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09834-2 · Cited by 103
Cillo, A. R., Mukherjee, E., Bailey, N. G., Onkar, S., Daley, J. D., Salgado, C. M., Li, X., Liu, D., Ranganathan, S., Burgess, M. A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-1471 · Cited by 102
A tumor microenvironment-based prognostic index for osteosarcoma
Wu, C., Gong, S., Duan, Y., Deng, C., Kallendrusch, S., Berninghausen, L. K., Osterhoff, G., & Schopow, N. (2023) · Journal of Biomedical Science · doi:10.1186/s12929-023-00917-3 · Cited by 107
“In addition, low immune cell infiltration levels in TME not only represent lower anti-tumor immunity, but also help tumor cells to evade immune attacks [16, 17].”
BackgroundMethodProteogenomic analysis of chemo-refractory high-grade serous ovarian cancer
Chowdhury, S., Kennedy, J. J., Ivey, R. G., Murillo, O. D., Hosseini, N., Song, X., Petralia, F., Calinawan, A. P., Savage, S. R., Berry, A. B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.07.004 · Cited by 112
NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma
Brennan, K., Shin, J. H., Tay, J. K., Prunello, M., Gentles, A. J., Sunwoo, J. B., & Gevaert, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-17298-x · Cited by 96
“This T cell score was strongly correlated with expression of CD8+ T cell expressed PDCD1 and negatively associated with expression of EPCAM, a marker of epithelial tumor purity (Low stromal/immune content) (35) (Supplementary figure 1).”
Wei, Z., Chen, L., Meng, L., Han, W., Huang, L., & Xu, A. (2020) · Gastric Cancer · doi:10.1007/s10120-020-01091-3 · Cited by 94
“The ESTIMATE algorithm was adopted to calculate the ESTIMATE, stromal and immune scores of GC tissues [21].”
MethodZhang, F., Zhang, Q., Zhu, J., Yao, B., Ma, C., Qiao, N., He, S., Ye, Z., Wang, Y., Han, R., et al. (2022) · Cell Research · doi:10.1038/s41422-022-00736-5 · Cited by 111
Hallmarks of sex bias in immuno-oncology: mechanisms and therapeutic implications
Xiao, T., Lee, J., Gauntner, T. D., Velegraki, M., Lathia, J. D., & Li, Z. (2024) · Nature reviews. Cancer · doi:10.1038/s41568-024-00680-z · Cited by 99
“Across cancers, Han et al. 207 showed that male individuals have significantly higher TMB and lower immune cell gene signature 208 than female individuals.”
Prognostic power of a lipid metabolism gene panel for diffuse gliomas
Wu, F., Zhao, Z., Chai, R., Liu, Y., Li, G., Jiang, H., & Jiang, T. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14647 · Cited by 112
Liu, J., Kong, X., Huang, T., Wang, R., Li, W., & Chen, Q. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02048 · Cited by 103
“Estimating Relative Subsets of RNA Transcripts (CIBERSORT) is a metagene tool that can be used to predict the phenotypes of 22 human immunocytes, as previously reported for all TCGA samples (23).”
MethodXu, W., Zhang, J., Hua, Y.-T., Yang, S., Wang, D., & Tang, J.-H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.605097 · Cited by 103
“T (Tfh) cells, T-helper 1 (Th1) cells, T-helper 2 (Th2) cells, Thelper 17 (Th17) cells, exhausted T cells, Tregs, and Mast cells (20).”
Removing unwanted variation from large-scale RNA sequencing data with PRPS
Molania, R., Foroutan, M., Gagnon-Bartsch, J. A., Gandolfo, L. C., Jain, A., Sinha, A., Olshansky, G., Dobrovic, A., Papenfuss, A. T., & Speed, T. P. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01440-w · Cited by 98
Janku, F., Han, S.-W., Doi, T., Amatu, A., Ajani, J. A., Kuboki, Y., Cortez, A., Cellitti, S. E., Mahling, P. C., Subramanian, K., et al. (2022) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-21-0722 · Cited by 84
Wang, L., Sebra, R., Sfakianos, J. P., Allette, K., Wang, W., Yoo, S., Bhardwaj, N., Schadt, E. E., Yao, X., Galsky, M. D., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0720-0 · Cited by 113
“We also employed other available gene expression deconvolution methods, i.e., ESTIMATE [6], the absolute version of CIBERSORT [8], EPIC [34], quanTIseq [35], and ISOpure [14].”
BackgroundMethodResultWu, Y., Zhang, L., He, S., Guan, B., He, A., Yang, K., Gong, Y., Li, X., & Zhou, L. (2020) · Aging · doi:10.18632/aging.104115 · Cited by 112
Lin, Z., Qian, X., Miao, D., & Yu, F. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.644416 · Cited by 105
“Tumor Microenvironment and Immune Response Analysis The infiltration levels of immune cells and stromal cells in different tumor tissues were analyzed by immune score and stromal score (15).”
BackgroundDeng, L., Liu, S., Xu, J., Chen, L., Xu, C., Chen, F.-T., Xu, Z., Zhang, Y., Xia, S., Shao, Y., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16458 · Cited by 100
Zheng, S., Zou, Y., Tang, Y., Yang, A., Liang, J.-Y., Wu, L., Tian, W., Xiao, W., Xie, X., Yang, L., et al. (2022) · OncoImmunology · doi:10.1080/2162402x.2021.2020984 · Cited by 105
“The estimation of stromal and immune cells in malignant tumor tissues using expression data (ESTIMATE) was applied to calculate the overall stromal and immune scores in cancer.(42)”
MethodOrth, M. F., Surdez, D., Faehling, T., Ehlers, A. C., Marchetto, A., Grossetête, S., Volckmann, R., Zwijnenburg, D. A., Gerke, J. S., Zaïdi, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111761 · Cited by 92
Kurebayashi, Y., Emoto, K., Hayashi, Y., Kamiyama, I., Ohtsuka, T., Asamura, H., & Sakamoto, M. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0214 · Cited by 99
TP53 Mutations Promote Immunogenic Activity in Breast Cancer
Liu, Z., Jiang, Z., Gao, Y., Wang, L., Chen, C., & Wang, X. (2018) · Journal of Oncology · doi:10.1155/2019/5952836 · Cited by 99
Analyzing and validating the prognostic value and mechanism of colon cancer immune microenvironment
Wang, X., Duanmu, J., Fu, X., Li, T., & Jiang, Q. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02491-w · Cited by 102
“In order to validated that those 3 subgroups are different in immunity, we use a R package called “estimate” to calculate the immune score, stromal score and ESTIMATE score of every tumor sample [31].”
MethodLiu, L., Mo, M., Chen, X., Chao, D., Zhang, Y., Chen, X., Wang, Y., Zhang, N., He, N., Yuan, X., et al. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02647-8 · Cited by 98
“enrichment for LMrisk The Estimation of Stromal and Immune cells in Malignant Tumors using Expression data (ESTIMATE) was used to evaluate the immune score, stromal score and ESTIMATE score of each sample [24].”
MethodLarge-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma
Zhang, C., Zhang, Z., Li, F., Shen, Z., Qiao, Y., Li, L., Liu, S., Song, M., Zhao, X., Ren, F., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1461304 · Cited by 104
“To fully understand the relationship between B7-H3 expression with immune cell infiltration, ESTIMATE algorithm analyze was used.(18) In CGGA RNA-seq and TCGA RNA-seq datasets,”
MethodYang, Z., Liang, X., Fu, Y., Liu, Y., Zheng, L., Liu, F., Li, T., Yin, X., Xu, Q., & Xu, X. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.013 · Cited by 103
de Jong, J. J., Liu, Y., Robertson, A. G., Seiler, R., Groeneveld, C. S., van der Heijden, M. S., Wright, J. L., Douglas, J., Dall’Era, M., Crabb, S. J., et al. (2019) · Genome Medicine · doi:10.1186/s13073-019-0669-z · Cited by 90
“Sample purity was calculated by the ABSOLUTE and ESTIMATE algorithms for the TCGA and NAC cohorts, respectively [23, 24].”
MethodLi, B., Jiang, Y., Li, G., Fisher, G. A., & Li, R. (2020) · JCI Insight · doi:10.1172/jci.insight.136570 · Cited by 95
“Clinicopathologic and treatment information for patients in the GEP and IHC 602 cohorts 603 GEP cohorts IHC cohorts ACRG GSE15459 GSE84437 TCGA STAD SMU1 SMU2 SYSU Number of patients 300 192 433 415 247 234 272 Median age (range) 64 (24-86) 67 (23-92) 62 (27-86) 67 (30-90) 57 (23-90) 55 (21-77) 58 (24-82) Male (%) 199…”
MethodYang, J., Shi, X., Yang, M., Luo, J., Gao, Q., Wang, X., Wu, Y., Tian, Y., Wu, F., & Zhou, H. (2021) · International Journal of Oral Science · doi:10.1038/s41368-021-00115-7 · Cited by 88
“Contrary findings concerning the respective levels of H19 expression in OSCC may be due to differences in the number and composition of the tissues used, while infiltrating stromal and immune cells are also the key components of tumor tissue.(57) Contrary findings on lncRNA H19 mechanisms of action have also been repo…”
BackgroundBao, J.-H., Lu, W., Duan, H., Ye, Y.-Q., Li, J., Liao, W., Li, Y., & Sun, Y.-P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.933973 · Cited by 96
“R package “ESTIMATE” can calculate TME scores including the stromal score, immune score, and estimate score using gene expression profiles (29).”
MethodDinh, T. A., Vitucci, E. C. M., Wauthier, E., Graham, R. P., Pitman, W. A., Oikawa, T., Chen, M., Silva, G. O., Greene, K. G., Torbenson, M. S., et al. (2017) · Scientific Reports · doi:10.1038/srep44653 · Cited by 90
Qin, Y., Feng, H., Chen, M., Wu, H., & Zheng, X. (2018) · Genes & Diseases · doi:10.1016/j.gendis.2018.02.003 · Cited by 94
Zheng, S., Zou, Y., Liang, J., Xiao, W., Yang, A., Meng, T., Lu, S., Luo, Z.-B., & Xie, X. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12747 · Cited by 101
Esteban-Fabró, R., Willoughby, C. E., Piqué‐Gili, M., Montironi, C., Abril‐Fornaguera, J., Peix, J., Torrens, L., Mesropian, A., Balaseviciute, U., Miró‐Mur, F., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-2517 · Cited by 91
Dong, W., Li, J., & Zhuang, Z. (2024) · Aging · doi:10.18632/aging.205376 · Cited by 94
“[55].”
Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma
Liu, S., Zhang, C., Maimela, N. R., Li, Y., Zhang, Z., Yü, P., Huang, L. J., & Zhang, Y. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1601478 · Cited by 92
Zheng, X., Zhao, Q. C., Wu, H., Li, W., Wang, H., Meyer, C. A., Qin, Q., Xu, H., Zang, C., Jiang, P., et al. (2014) · Genome biology · doi:10.1186/preaccept-9737754001327268 · Cited by 92
Chen, Z., Guo, Y., Zhao, D., Zou, Q., Yu, F., Zhang, L., & Xu, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.808208 · Cited by 87
Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis
Bormann, F., Rodríguez-Paredes, M., Lasitschka, F., Edelmann, D., Musch, T., Benner, A., Bergman, Y., Dieter, S. M., Ball, C. R., Glimm, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.045 · Cited by 86
Wang, W., Zhang, J., Wang, Y., Xu, Y., & Zhang, S. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.06.046 · Cited by 88
Zeleke, T. Z., Pan, Q., Chiuzan, C., Onishi, M., Li, Y., Tan, H., Alvarez, M. J., Honan, E., Yang, M., Chia, P. L., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00489-5 · Cited by 78
Consensus molecular subtype classification of colorectal adenomas
Komor, M. A., Bosch, L. J., Bounova, G., Bolijn, A. S., Delis‐van Diemen, P. M., Rausch, C., Hoogstrate, Y., Stubbs, A. P., de Jong, M., Jenster, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5129 · Cited by 86
“the ESTIMATE algorithm [33] was used, as well as single-sample GSEA with the GSVA Bioconductor package [34], with the ‘invasive front’ and ‘central tumour’ signatures [35].”
MethodResultSveen, A., Johannessen, B., Tengs, T., Danielsen, S. A., Eilertsen, I. A., Lind, G. E., Berg, K. C. G., Leithe, E., Meza-Zepeda, L. A., Domingo, E., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0434-0 · Cited by 85
“To analyze the association between genetic changes and infiltration of immune cells, the latter was evaluated based on gene expression using the algorithm MCPcounter [43] and the immune-score ESTIMATE [66].”
InfluentialTranscriptome Deconvolution of Heterogeneous Tumor Samples with Immune Infiltration
Wang, Z., Cao, S., Morris, J. S., Ahn, J., Liu, R., Tyekucheva, S., Gao, F., Li, B., Lü, W., Tang, X., et al. (2018) · iScience · doi:10.1016/j.isci.2018.10.028 · Cited by 99
Fujita, M., Yamaguchi, R., Hasegawa, T., Shimada, S., Arihiro, K., Hayashi, S., Maejima, K., Nakano, K., Fujimoto, A., Ono, A., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102659 · Cited by 87
“The ESTIMATE immune score [25] and the immune classes proposed by Sia et al.”
BackgroundXu, S., Tang, L., Dai, G., Luo, C., & Liu, Z. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.594112 · Cited by 85
Guo, W., Tan, F., Huai, Q., Wang, Z., Shao, F., Zhang, G., Yang, Z., Li, R., Xue, Q., Gao, S., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.669750 · Cited by 92
“Subsequently, the ESTIMATE algorithm (“estimate” package in R) was used to calculate the immune score of each patient, and the difference in the immune score between the two cluster subgroups was evaluated (21).”
MethodZhang, P., Pei, S., Gong, Z., Feng, Y., Zhang, X., Yang, F., & Wang, W. T. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1115272 · Cited by 86
“Based on the expression profiles, the R package “estimate” was used to infer malignant tumor tissues’ stromal and immune cell abundance and tumor purity (29).”
MethodHuang, J., Zhang, J., Zhang, F., Lu, S., Guo, S., Shi, R., Zhai, Y., Gao, Y., Tao, X., Jin, Z., et al. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107402 · Cited by 95
TumorMap: Exploring the Molecular Similarities of Cancer Samples in an Interactive Portal
Newton, Y., Novak, A. M., Swatloski, T., McColl, D. C., Chopra, S., Graim, K., Weinstein, A. S., Baertsch, R., Salama, S. R., Ellrott, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0580 · Cited by 84
“S4A); enriched for ESTIMATE (12) immune signaling scores (Supplementary Methods; Supplementary Fig.”
BackgroundPancreatic cancer survival analysis defines a signature that predicts outcome
Raman, P., Maddipati, R., Lim, K., & Tözeren, A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201751 · Cited by 96
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Vitiello, G. A., Bowler, T. G., Liu, M., Medina, B. D., Zhang, J. Q., Param, N. J., Loo, J. K., Goldfeder, R. L., Chibon, F., Rossi, F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124108 · Cited by 91
“ESTIMATE and CYT scoring, which infer the quantity and cytolytic activity of the immune infiltrates, respectively (23, 24), revealed that KIT-mutant GIST had a range of immune cell scape.”
Chen, Y., Huang, Y., Gao, X., Li, Y., Lin, J., Chen, L., Chang, L., Chen, G., Guan, Y., Pan, L. K., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01620 · Cited by 101
“We found that the median ESTIMATE score in the CCND1 amplification group was significantly inferior to that in the neutral group (−849.10 vs. −696.23, P = 0.0051; Figure 3A).”
MethodInfluential
Metadata
- Authors
- Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., Carter, S. L., Getz, G., Stemke-Hale, K., Mills, G. B., & Verhaak, R. G. W.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- University of Southern California (US)
- Memorial Sloan Kettering Cancer Center (US)
- Broad Institute (US)
- Corresponding author
- Verhaak, Roel G.W.
- ORCID
- Venue
- Nature Communications
- Published
- 2013-10-11
- Volume
- 4
- Issue
- 1
- Pages
- 2612-2612
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3826632
- OpenAlex
- W2130430382
- Cited by
- 9,778
- References
- 63
- Citations by year
- 2026: 694 · 2025: 1176 · 2024: 1602 · 2023: 1755 · 2022: 1988 · 2021: 1316 · 2020: 683 · 2019: 223 · 2018: 121 · 2017: 93 · 2016: 53 · 2015: 39 · 2014: 20 · 2013: 2
- FWCI
- 17.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Texas MD Anderson Cancer Center
- National Cancer Institute (P50CA098258, U24CA143882, CA143883, U24CA143883, P30CA008748, P30CA016672)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Single-cell and spatial transcriptomics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Keywords
- tumor purity, tumor stroma, tumor-infiltrating immune cells, gene expression signatures, tumor microenvironment, DNA copy number, cancer transcriptomics
- MeSH terms
- Algorithms, Cell Separation, Female, Humans, Leukocytes, Neoplasms, Research Design, Sensitivity and Specificity, Software, Gene Library, Genome, Human, Stromal Cells, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, DNA Copy Number Variations, High-Throughput Nucleotide Sequencing, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.